Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001862468 | SCV002170566 | uncertain significance | not provided | 2021-10-09 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine with proline at codon 357 of the TPP1 protein (p.Ala357Pro). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and proline. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with TPP1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001827393 | SCV002094831 | uncertain significance | Neuronal ceroid lipofuscinosis 2 | 2020-11-02 | no assertion criteria provided | clinical testing |